This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PROK1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PROK1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~11.7 kDa | |
| Observed band | ~20 kDa | |
| Gel | 12–15% | |
| Negative control | siRNA / KO lysate |
| PTM | Cleaved | |
| Caveat | Multiple disulfide bonds | |
| Regulation | Upregulated (immune signature) | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for PROK1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | MCF-7 . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Prokineticin 1 antigen affinity purified polyclonal antibody (Catalog # PB9881) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Prokineticin 1 at approximately 20 kDa. The expected band size for Prokineticin 1 is at 12 kDa |
| Gel % | 12–15% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 20 kDa |
PROK1 has an 11.7 kDa predicted precursor but its disulfide-stabilized secreted mature protein runs at approximately 20 kDa on SDS-PAGE due to a compact, SDS-resistant fold, not glycosylation.
| single band near 20 kDa | the empirical migration position of mature secreted PROK1, far above its calculated mass because its disulfide-stabilized fold resists normal SDS unfolding |
| band smaller than the 11.7 kDa full-length precursor mass | removal of the 19-residue signal peptide during secretion yields a mature chain lighter than the unprocessed precursor |
| little or no band in whole-cell lysate | PROK1 is a secreted protein, so it is efficiently exported and does not accumulate intracellularly |
| sharp band without smearing | PROK1 has no glycosylation sites, so no glycoform heterogeneity or sugar-driven smear is expected |
| shifted or additional band under non-reducing or partially reducing conditions | PROK1 carries five disulfide bonds; incomplete reduction leaves residual disulfide-constrained conformers that migrate differently |
| single band, no doublets | only one PROK1 isoform is reported, so no alternate-splice-driven second band is expected |
| Predicted precursor mass (11.7 kDa, 105 aa) | sets the theoretical baseline size before any processing or folding effects are applied |
| Signal peptide cleavage (residues 1-19) | removes the N-terminal signal sequence during secretion, making the true mature chain lighter than the full-length precursor value |
| Five disulfide bonds (e.g. Cys26-Cys38, Cys32-Cys50, Cys37-Cys78, Cys60-Cys86, Cys80-Cys96) | lock the mature protein into a compact, SDS-resistant conformation that migrates markedly slower than its linear mass, producing the ~20 kDa apparent band |
| Absence of glycosylation sites | rules out glycan-driven mass increase or smearing, so the upward shift in apparent size is structural, not carbohydrate-based |
| Secreted subcellular localization | shifts detection toward conditioned media or biofluids, with correspondingly weaker signal expected in standard whole-cell lysates |
| Single reported isoform | no alternative splice forms are expected to appear as additional bands |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PROK1 is actively secreted and does not accumulate inside cells | probe conditioned media, serum, or plasma instead of, or in addition to, whole-cell lysate |
| Band higher than expected | the five disulfide bonds create a compact fold that resists complete SDS denaturation, and incomplete reduction compounds the effect | increase reducing agent concentration and boiling time to ensure full unfolding before comparing to the ~20 kDa reference band |
| Multiple bands | partial reduction of the five disulfide bonds yields a mixture of fully reduced and partially oxidized species with different mobilities | extend incubation with fresh DTT or beta-mercaptoethanol and re-run to collapse the mixture into a single species |
| Fragments below expected size | the small, disulfide-rich chain is susceptible to proteolytic clipping during sample handling | add protease inhibitors and keep samples cold throughout lysis and preparation |
| Weak or no signal | secreted PROK1 is present at low abundance in standard lysates relative to conditioned media or biofluids | concentrate the secreted fraction, load more protein, and use a high-sensitivity detection substrate |
| Broad smear instead of sharp band | residual, unevenly reduced disulfide bonds can produce a spread of closely spaced conformers rather than glycosylation-driven smearing | verify complete reduction and fresh reducing agent, since PROK1 has no glycosylation sites to explain smearing |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for PROK1, answered from its protein features.
BosterBio's PROK1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-PROK1 antibodies are top-performing, extensively cited, and rigorously validated through orthogonal approaches such as negative-tissue controls, delivering dependable, specific Western blot detection of Prokineticin 1 you can trust for consistent results.
Which to pick: Both PB9881 and PB9882 are validated with real Western blot images for Prokineticin 1 detection; either performs reliably, so selection can be based on availability, host species, or lot preference.